ATE548080T1 - Verfahren zur wiederherstellung der erektilen funktion - Google Patents

Verfahren zur wiederherstellung der erektilen funktion

Info

Publication number
ATE548080T1
ATE548080T1 AT08771042T AT08771042T ATE548080T1 AT E548080 T1 ATE548080 T1 AT E548080T1 AT 08771042 T AT08771042 T AT 08771042T AT 08771042 T AT08771042 T AT 08771042T AT E548080 T1 ATE548080 T1 AT E548080T1
Authority
AT
Austria
Prior art keywords
erectile function
nitric oxide
restoring
restoring erectile
cells
Prior art date
Application number
AT08771042T
Other languages
English (en)
Inventor
James Yoo
Anthony Atala
Original Assignee
Univ Wake Forest Health Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wake Forest Health Sciences filed Critical Univ Wake Forest Health Sciences
Application granted granted Critical
Publication of ATE548080T1 publication Critical patent/ATE548080T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT08771042T 2007-06-13 2008-06-13 Verfahren zur wiederherstellung der erektilen funktion ATE548080T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94376207P 2007-06-13 2007-06-13
PCT/US2008/066944 WO2008157368A1 (en) 2007-06-13 2008-06-13 Methods of restoration of erectile function

Publications (1)

Publication Number Publication Date
ATE548080T1 true ATE548080T1 (de) 2012-03-15

Family

ID=40156630

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08771042T ATE548080T1 (de) 2007-06-13 2008-06-13 Verfahren zur wiederherstellung der erektilen funktion

Country Status (11)

Country Link
US (1) US20100173006A1 (de)
EP (1) EP2162189B1 (de)
JP (1) JP2010529895A (de)
KR (1) KR20100063693A (de)
CN (1) CN101848746A (de)
AT (1) ATE548080T1 (de)
AU (1) AU2008265973A1 (de)
CA (1) CA2690383A1 (de)
DK (1) DK2162189T3 (de)
ES (1) ES2382022T3 (de)
WO (1) WO2008157368A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101275224B1 (ko) * 2010-10-20 2013-06-14 인하대학교 산학협력단 지방조직-유래된 기질혈관분획을 유효성분으로 포함하는 발기부전 예방 또는 치료용 조성물
CN102652670A (zh) * 2011-03-01 2012-09-05 三维医疗科技江苏股份有限公司 一种神经电生理男性性功能检测仪
JP2013198410A (ja) * 2012-03-23 2013-10-03 Hitachi High-Technologies Corp 液中グラム染色法及び微生物検査方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1995970A (en) * 1931-04-04 1935-03-26 Du Pont Polymeric lactide resin
US2676945A (en) * 1950-10-18 1954-04-27 Du Pont Condensation polymers of hydroxyacetic acid
US2683136A (en) * 1950-10-25 1954-07-06 Du Pont Copolymers of hydroxyacetic acid with other alcohol acids
US2703316A (en) * 1951-06-05 1955-03-01 Du Pont Polymers of high melting lactide
US2758987A (en) * 1952-06-05 1956-08-14 Du Pont Optically active homopolymers containing but one antipodal species of an alpha-monohydroxy monocarboxylic acid
DE1228416B (de) * 1957-03-04 1966-11-10 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Polyestern
US3531561A (en) * 1965-04-20 1970-09-29 Ethicon Inc Suture preparation
US4251387A (en) * 1979-04-17 1981-02-17 Damon Corporation Process for preparing semipermeable microcapsules
US5514378A (en) * 1993-02-01 1996-05-07 Massachusetts Institute Of Technology Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
US5654273A (en) * 1994-09-22 1997-08-05 Children's Medical Center Corporation Synducin mediated modulation of tissue repair
US5594032A (en) * 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
JPH11501512A (ja) * 1995-03-03 1999-02-09 メタボレックス，インコーポレイティド ゲル化ポリマーによる新規の被包方法
US5980887A (en) * 1996-11-08 1999-11-09 St. Elizabeth's Medical Center Of Boston Methods for enhancing angiogenesis with endothelial progenitor cells
US20030119714A1 (en) * 2000-12-15 2003-06-26 Naylor Alasdair Mark Treatment of male sexual dysfunction
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US8940292B2 (en) * 2003-01-28 2015-01-27 Wake Forest University Health Sciences Enhancement of angiogenesis to grafts using cells engineered to produce growth factors
EP1469064A1 (de) * 2003-04-15 2004-10-20 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Expression von Proteinen in endothelialen Zellen, die von Vorläuferzellen aus Nabelschnurblut abgeleitet wurden
US8192348B2 (en) * 2003-07-01 2012-06-05 Regents Of The University Of Minnesota Engineered blood vessels
US20050050228A1 (en) * 2003-08-29 2005-03-03 Michael Perham Method and apparatus for the use of dynamic XML message formats with web services
CN1621094A (zh) * 2003-11-26 2005-06-01 犹太大学阿尔伯特爱因斯坦医学院 用于调节平滑肌张力的基因转移
WO2005078073A2 (en) * 2004-02-09 2005-08-25 Indiana University Research And Technology Corporation Isolation, expansion and of clonogenic endothelial progenitor cells
US8372797B2 (en) * 2006-06-22 2013-02-12 Creative Medical Health, Inc. Treatment of erectile dysfunction by stem cell therapy

Also Published As

Publication number Publication date
AU2008265973A1 (en) 2008-12-24
CA2690383A1 (en) 2008-12-24
WO2008157368A1 (en) 2008-12-24
EP2162189B1 (de) 2012-03-07
EP2162189A4 (de) 2011-01-05
CN101848746A (zh) 2010-09-29
EP2162189A1 (de) 2010-03-17
KR20100063693A (ko) 2010-06-11
DK2162189T3 (da) 2012-04-02
ES2382022T3 (es) 2012-06-04
JP2010529895A (ja) 2010-09-02
US20100173006A1 (en) 2010-07-08

Similar Documents

Publication Publication Date Title
MX2012007413A (es) Diferenciacion de celulas madre embrionarias humanas.
ES2572211T3 (es) Regeneración de músculo esquelético utilizando células madre mesenquimales
MX2022008277A (es) Composiciones de gel para administracion transdermica para maximizar las concentraciones de farmaco en el estrato corneo y suero, y metodos de uso de las mismas.
GB2458006B (en) Methods of making a mixture for a PTFE membrane with metal oxides
MX2009011055A (es) Tratamiento de la enfermedad de gaucher con chaperonas farmacologicas especificas y supervision del tratamiento utilizando marcadores sustitutos.
CL2015002914A1 (es) Tratamiento de la diabetes mellitus mediante formulaciones de la insulinas de acción prolongada
ATE548080T1 (de) Verfahren zur wiederherstellung der erektilen funktion
BR112018010946A2 (pt) método para enriquecimento de células endócrinas pancreáticas, população enriquecida de células endócrinas pancreáticas, método de tratamento de diabetes e método de preparação de células beta de produção de insulina
MX2016008568A (es) Composiciones y metodos para proveer telomerasa activa a las celulas in vivo.
MX337850B (es) Lipoatrofia cosmetica medicinal.
PE20121537A1 (es) Combinacion de teobromina con un descongestivo
MX2015009606A (es) Uso de un péptido natriurético, un péptido diurético o un péptido vasodilatador en la elaboración de un medicamento para tratar una condición cardiovascular.
EA201370202A1 (ru) Устройство для ротовой полости
GB2533734A (en) Freeze/thaw stable latex emulsion for treatment of well bore tar
UA44395U (ru) Применение тиоцетама в качестве диуретического средства с мягким мочегонным действием в комплексном лечении
PH12015502068A1 (en) Treatment of insulin resistance associated with prolonged physical inactivity
GEP20196947B (en) Bremelanotide therapy for female sexual dysfunction
UA80369U (ru) Способ лечения мультирезистентного туберкулеза легких
UA38340U (ru) Способ лечения женщин с патологическим прелиминарным периодом
UA76797U (ru) Способ лечения синдрома преждевременной эякуляции
UA56675U (ru) Способ местного лечения генерализованного пародонтита c использованием синглетно-кислородной терапии
UA57863U (ru) Способ оценки эффективности лечения генерализованного пародонтита у больных красным плоским лишаем
UA79085U (ru) Способ лечения никотиновой зависимости
TR200703753A2 (tr) Füme hamsi üretim yöntemi
UA38268U (ru) Способ оценки эффективности применения адаптола